SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera is trending as investors debate its long-term potential amid significant price volatility and recent negative developments, including the cancellation of planned ETFs. While some traders view the current levels as a buying opportunity based on Hedera's institutional infrastructure and upcoming tokenization use cases, others express frustration over the asset's sustained decline and perceived lack of price momentum.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is trending primarily due to its recent listing on the Upbit exchange, which has triggered a significant surge in trading volume and speculative interest. While some traders are reacting to the increased volatility with bullish optimism, others remain skeptical, frequently dismissing the price movement as a pump-and-dump scheme.

XYO is the original and one of the largest Decentralized Physical Infrastructure Networks (DePIN), boasting over 10 million nodes and consistently leading DePIN in both scale and revenue generation. Launching its Mainnet ahead of any other DePIN, XYO specializes in collecting and validating real-world data, bridging it seamlessly to Web3 and Web2 companies across AI, geolocation, and other critical data sectors. At the core of XYO are Proof of Location and Proof of Origin technologies, enabling accurate validation of real-world data for innovative use cases such as Real-World Asset (RWA) tracking, DePIN applications, real-world gaming, and treasure hunts. Recently, XYO expanded its ecosystem by launching the XYO Layer One blockchain, purpose-built to support the intensive data demands of DePIN, RWA, AI, and similar data-driven industries. XYO employs a unique dual-token model: XYO Token: An externally traded token supporting the DePIN ecosystem, rewards, staking, and governance, enhancing overall ecosystem value and scarcity.   XL1 Token: Internal to the XYO Layer One blockchain, facilitating transactions, gas fees, and other blockchain-specific use cases. The dual-token economics are strategically designed to increase scarcity and promote sustainable growth. The XYO token is available on major exchanges, including Coinbase. The XL1 token will launch publicly later in 2025. To accelerate network adoption and growth, XYO created the popular COIN app. Beyond the XYO Foundation, the team founded the U.S.-based, for-profit entity XY Labs Inc., notable as the first U.S. crypto company qualified by the SEC for a Regulation A offering, permitting share sales to both accredited and non-accredited investors. XY Labs further stands out as one of the pioneering U.S. companies to tokenize and publicly list its shares. These tokenized shares trade as $XYLB on the tZERO ATS, positioning XY Labs prominently in the growing wave of Real-World Asset (RWA) tokenization.

XYO Network

The community discussion is heavily fragmented between speculative traders anticipating a major breakout driven by upcoming network developments and vocal critics labeling the project a pump-and-dump scheme. Skepticism remains high regarding leadership's communication and the failure to maintain price gains, while long-term holders continue to emphasize the utility of the network's spatial data technology.

Constellation Energy Corp. engages in the generation, supply, and marketing of clean electricity, and renewable energy products and solutions. The firm also offers wholesale energy, retail products and services. It operates under the following geographical segments: Mid-Atlantic, Midwest, New York, Electric Reliability Council of Texas (ERCOT), and Other Power Regions Segment. The company was founded in 1960 and is headquartered in Baltimore, MD.

Constellation Energy Corporation

Constellation Energy is trending as investors monitor the company's role as a major power supplier for data centers amid an AI-driven energy demand surge. While some participants express frustration over recent price volatility and concerns regarding debt levels following acquisitions, others remain bullish on the long-term potential of the firm's nuclear fleet to provide carbon-free baseload electricity.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is trending as market participants debate its potential as a post-quantum secure blockchain, with supporters highlighting recent mainnet upgrades and institutional integrations while skeptics point to historical price declines and supply dilution. The conversation remains highly polarized between long-term accumulators targeting a price recovery and vocal critics who characterize the project as a declining asset.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is surging as traders point to a combination of heavy short liquidations, institutional attention, and excitement over a potential exchange-traded fund. While many users are celebrating the privacy-focused asset's parabolic rally to new highs, some remain skeptical, labeling the rapid price action a speculative pump.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol Myers Squibb is trending as investors monitor its pipeline development and long-term strategy to counter upcoming patent cliffs for major products like Eliquis and Opdivo. The discussion centers on the company's focus on growth-oriented assets, including its CELMoD program and strategic AI collaborations, to offset revenue erosion from legacy drugs.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as investors monitor the company's progress toward the commercialization of its lead gene-editing candidate, lonvo-z, amid anticipation of upcoming FDA filing developments and potential priority review. Community sentiment is largely driven by optimism regarding the company's strong cash position and the non-dilutive nature of recent financing, while some traders continue to monitor high short interest as a catalyst for a potential short squeeze.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is experiencing a mix of bullish sentiment from traders anticipating a broader crypto market breakout and skepticism from those viewing it as a stagnant meme coin. Discussions are heavily focused on technical chart patterns and speculative price targets as the community debates whether the token can reach higher valuations alongside other major cryptocurrencies.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics is experiencing price volatility as the community remains divided over the company's path to profitability, with many traders expressing skepticism regarding the management's reliance on dilution and the lack of robust marketing. While some investors view the recent technology adoption and revenue growth as positive indicators of long-term viability, others are frustrated by the lack of transparency, ongoing share price weakness, and the high cash burn rate.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What's Going On With SANUWAVE Health Stock On Friday?

NASDAQ:SNWV shares are trading down 0.5% in premarket as SANUWAVE Health beats Q2 revenue expectations, but faces financial constraints and competition.read more...

SANUWAVE Health Inc Reports Q1 2026 Results: Full Earnings Call Transcript

SANUWAVE Health Inc Reports Q1 2026 Results: Full Earnings Call Transcript...

Sanuwave Health Inc. (SNWV) Reports Q1 Loss, Beats Revenue Estimates

Sanuwave Health (SNWV) delivered earnings and revenue surprises of -21.43% and +0.20%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

biote Corp. (BTMD) Q1 Earnings and Revenues Lag Estimates

biote Corp. (BTMD) delivered earnings and revenue surprises of -33.33% and -2.71%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Will MacroGenics (MGNX) Report Negative Q1 Earnings? What You Should Know

MacroGenics (MGNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Insider Unloading: Opaleye Management Inc Sells $1.27M Worth Of SANUWAVE Health Shares

Sanuwave Health Inc. (SNWV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Sanuwave Health (SNWV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sanuwave Health (SNWV) Expected to Announce Earnings on Friday

Sanuwave Health (NASDAQ:SNWV) will be releasing its Q1 2026 earnings before the market opens on Friday, May 8. (View Earnings Report at...

Analysts Set Expectations for Sanuwave Health Q1 Earnings

Sanuwave Health Inc. (NASDAQ:SNWV - Free Report) - Equities researchers at Northland Securities reduced their Q1 2026 earnings estimates for Sanuwave Health in a research report issued on Friday...

Sanuwave Health (NASDAQ:SNWV) Rating Lowered to "Strong Sell" at Zacks Research

Zacks Research cut Sanuwave Health from a "hold" rating to a "strong sell" rating in a report on Monday...

• Reported GAAP EPS of -$0.08 down -233.33% YoY
• Reported revenue of $9.74M down -3.13% YoY

SANUWAVE Health, Inc. experienced a shift to net loss, declining system revenue driven by lower volume and pricing, and ongoing material weaknesses in internal control over financial reporting.

SANUWAVE Health, Inc. achieved growth in consumables revenue, a significant reduction in net loss for the six-month period, and improved other expense metrics due to lower interest costs.

SANUWAVE Health, Inc. is a medical device company providing directed energy products into the wound care space. It engages in the development and marketing of directed energy products that utilize ultrasound technology. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.

Sanuwave Health Inc

Bullish Sentiment

The Federal Reserve hasn't raised rates at all in 2026, but hawkish comments from Fed Chair Kevin Warsh at the Jackson Hole symposium have pushed September rate hike odds as high as 66%, a sharp jump from under 40% just a week earlier. How many rate hikes do you expect from the Fed in 2026? Vote and explain your reasoning in the comments.

How many rate hikes do you expect from the Fed in 2026?

Feed

News

Sentiment

Earnings

Fundamentals

Info

SNWV SANUWAVE Health, Inc.

Fundamentals

Latest SNWV News